Cargando…

Metalloproteinases in Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBD) are chronic inflammatory diseases of the gastrointestinal tract, encompassing two main disorders: Crohn’s disease (CD) and ulcerative colitis (UC). In both these pathologies, excessive and local immune response against luminal antigens promotes a pathological proces...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marônek, Martin, Marafini, Irene, Gardlík, Roman, Link, René, Troncone, Edoardo, Monteleone, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001665/ https://www.ncbi.nlm.nih.gov/pubmed/33790618 http://dx.doi.org/10.2147/JIR.S288280

Ejemplares similares

Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease
por: Maronek, Martin, et al.
Publicado: (2020)

Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders?
por: Marônek, Martin, et al.
Publicado: (2020)

Respiratory Tract Infections in Inflammatory Bowel Disease Patients Taking Vedolizumab: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Marafini, Irene, et al.
Publicado: (2021)

Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer
por: Troncone, Edoardo, et al.
Publicado: (2021)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2020)

Precision Medicine in Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2021)

The Citrullination-Neutrophil Extracellular Trap Axis in Chronic Diseases
por: Maronek, Martin, et al.
Publicado: (2022)

Smoking and colorectal cancer in inflammatory bowel disease: Quantity matters?
por: Marafini, Irene, et al.
Publicado: (2023)

Endoscopic Predictors of Neoplastic Lesions in Inflammatory Bowel Diseases Patients Undergoing Chromoendoscopy
por: Lolli, Elisabetta, et al.
Publicado: (2022)

Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer
por: Stolfi, Carmine, et al.
Publicado: (2020)

Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases
por: Belvoncikova, Paulina, et al.
Publicado: (2022)

Interleukin-34 promotes tumorigenic signals for colon cancer cells
por: Franzè, Eleonora, et al.
Publicado: (2021)

Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer
por: Troncone, Edoardo, et al.
Publicado: (2018)

Low frequency of COVID-19 in inflammatory bowel diseases
por: Marafini, Irene, et al.
Publicado: (2020)

Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK) Inhibitors
por: Troncone, Edoardo, et al.
Publicado: (2020)

Interleukin-34 Mediates Cross-Talk Between Stromal Cells and Immune Cells in the Gut
por: Monteleone, Giovanni, et al.
Publicado: (2022)

Frequency and Predictors of Dysplasia in Pseudopolyp-like Colorectal Lesions in Patients with Long-Standing Inflammatory Bowel Disease
por: De Cristofaro, Elena, et al.
Publicado: (2023)

Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
por: Di Fusco, Davide, et al.
Publicado: (2019)

Cell-Free Nucleic Acids and their Emerging Role in the Pathogenesis and Clinical Management of Inflammatory Bowel Disease
por: Kubiritova, Zuzana, et al.
Publicado: (2019)

Effect of Vedolizumab on Anemia of Chronic Disease in Patients with Inflammatory Bowel Diseases
por: Scarozza, Patrizio, et al.
Publicado: (2020)

Reversibility of Frail Phenotype in Patients with Inflammatory Bowel Diseases
por: Salvatori, Silvia, et al.
Publicado: (2023)

Targeting IL-34/MCSF-1R Axis in Colon Cancer
por: Monteleone, Giovanni, et al.
Publicado: (2022)

Association Between Celiac Disease and Cancer
por: Marafini, Irene, et al.
Publicado: (2020)

High Frequency of Undiagnosed Psychiatric Disorders in Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2020)

Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders
por: Teofani, Adelaide, et al.
Publicado: (2022)

Smad7 and Colorectal Carcinogenesis: A Double-Edged Sword
por: Troncone, Edoardo, et al.
Publicado: (2019)

Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update
por: O'Sullivan, Shane, et al.
Publicado: (2015)

MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer
por: Masi, Letizia, et al.
Publicado: (2022)

Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
por: Laudisi, Federica, et al.
Publicado: (2020)

Long COVID in Inflammatory Bowel Diseases
por: Salvatori, Silvia, et al.
Publicado: (2021)

Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms
por: Salvatori, Silvia, et al.
Publicado: (2023)

A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn’s Disease
por: Di Fusco, Davide, et al.
Publicado: (2020)

Role of Interleukin-34 in Cancer
por: Franzè, Eleonora, et al.
Publicado: (2020)

The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis
por: Stolfi, Carmine, et al.
Publicado: (2013)

A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study
por: Marafini, Irene, et al.
Publicado: (2021)

An Overview of the Role of Innate Lymphoid Cells in Gut Infections and Inflammation
por: Sedda, Silvia, et al.
Publicado: (2014)

NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals
por: Marafini, Irene, et al.
Publicado: (2019)

OC.14.1 SARS-COV-2 INFECTION DOES NOT WORSEN THE COURSE OF INFLAMMATORY BOWEL DISEASE IN THE LONG TERM
por: Neri, B., et al.
Publicado: (2023)

Nuclear and Mitochondrial Circulating Cell-Free DNA Is Increased in Patients With Inflammatory Bowel Disease in Clinical Remission
por: Vrablicova, Zuzana, et al.
Publicado: (2020)

Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate?
por: Monteleone, Giovanni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c5lok48nmnjf9juqcj5gu5iso0